Perspective on the treatment of non-small cell lung cancer in the context of potential sars-cov-2 infection during the pandemic

George Theodoropoulos, Katerina Albanis, Medhi Wangpaichitr

Research output: Contribution to journalArticlepeer-review

Abstract

SARS-CoV-2 infections are rising at an alarming rate and various aspects of this pandemic must be quickly and adequately addressed in order to enhance effective healthcare delivery and protect at risk populations such as cancer patients. Preventing Covid-19 infection must be a top system wide priority to avoid mortality, and considerable financial and disease burden. Most cancer patients, and in particular those with tumors resistant to chemotherapy are particularly vulnerable to infection. In this review, we connect potential viral infection of patients with lung tumors that have somewhat quiesced the immune response in the tumor microenvironment and categorize target molecules in metabolism that may be used to identify at risk patients leading to more effective treatment regimens; keeping continuity of therapy and disease prevention during a very tumultuous period of time surrounding the pandemic.

Original languageEnglish (US)
Pages (from-to)137-147
Number of pages11
JournalJournal of Current Science and Technology
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2021

Keywords

  • Immunosuppressive
  • Infection
  • Lung cancer
  • Metabolism
  • SARS-CoV-2
  • Treatment
  • Tumor microenvironment

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Perspective on the treatment of non-small cell lung cancer in the context of potential sars-cov-2 infection during the pandemic'. Together they form a unique fingerprint.

Cite this